Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 21, Issue 3, Pages 388-394
Publisher
Wiley
Online
2013-05-02
DOI
10.1111/ene.12176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The genetics of Parkinson's disease: Progress and therapeutic implications
- (2013) Andrew B. Singleton et al. MOVEMENT DISORDERS
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Novel One-step Immunoassays to Quantify α-Synuclein
- (2012) Michael Bidinosti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
- (2012) Brit Mollenhauer et al. JOURNAL OF NEURAL TRANSMISSION
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease
- (2011) Henk W. Berendse et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
- (2011) Min Shi et al. NEUROBIOLOGY OF AGING
- In vivo visualization of -synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
- (2010) A. Kikuchi et al. BRAIN
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Biological fluid biomarkers in neurodegenerative parkinsonism
- (2009) Michael Eller et al. Nature Reviews Neurology
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search